Sandbox:Amd: Difference between revisions
Jump to navigation
Jump to search
(59 intermediate revisions by 2 users not shown) | |||
Line 2: | Line 2: | ||
{{CMG}}; {{AE}} {{ADS}} | {{CMG}}; {{AE}} {{ADS}} | ||
==Differential diagnosis== | |||
<span style="font-size:85%">'''Abbreviations: Na=''' Natrium/ Sodium, '''ADH= [[Antidiuretic hormone]]''' | |||
POLYURIA<ref name="BhasinVelez2016">{{cite journal|last1=Bhasin|first1=Bhavna|last2=Velez|first2=Juan Carlos Q.|title=Evaluation of Polyuria: The Roles of Solute Loading and Water Diuresis|journal=American Journal of Kidney Diseases|volume=67|issue=3|year=2016|pages=507–511|issn=02726386|doi=10.1053/j.ajkd.2015.10.021}}</ref> | |||
{| class="wikitable" | |||
! colspan="2" rowspan="3" style="background:#4479BA; color: #FFFFFF;" |Mechanism | |||
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" |Etiology | |||
! colspan="6" style="background:#4479BA; color: #FFFFFF;" |Clinical manifestations | |||
! colspan="5" style="background:#4479BA; color: #FFFFFF;" |Paraclinical findings | |||
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" |Comments | |||
|- | |||
! colspan="6" style="background:#4479BA; color: #FFFFFF;" |Symptoms and signs | |||
! colspan="5" style="background:#4479BA; color: #FFFFFF;" |Lab findings/Urine exam | |||
|- | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Dysuria | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Nocturia | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Hesitancy | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Dribbling | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Hematuria | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Proteinuria | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Serum osmolarity | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" |S. ADH | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Urine osmolarity | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Water deprivation test | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" |ADH administration | |||
|- | |||
! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Increased intake of fluid | |||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Psychogenic polydipsia]]<ref name="pmid6860053">{{cite journal| author=Mellinger RC, Zafar MS| title=Primary polydipsia. Syndrome of inappropriate thirst. | journal=Arch Intern Med | year= 1983 | volume= 143 | issue= 6 | pages= 1249-51 | pmid=6860053 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6860053 }}</ref> | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Low | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Improves urine osmolarity | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |No improvement | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Increased thirst | |||
|- | |||
! rowspan="3" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Increased solute excretion | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |Osmotic causes | |||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Diabetes mellitus]]<ref name="pmid104991902">{{cite journal| author=Ahloulay M, Schmitt F, Déchaux M, Bankir L| title=Vasopressin and urinary concentrating activity in diabetes mellitus. | journal=Diabetes Metab | year= 1999 | volume= 25 | issue= 3 | pages= 213-22 | pmid=10499190 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10499190 }}</ref> | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Late stage | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |High in Type 2 | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |No effect | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |No effect | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hyperosmolar hyperglycemic state]] | |||
|- | |||
! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Salt loss | |||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Diuretics]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Raised<ref name="pmid21468197">{{cite journal| author=Hwang KS, Kim GH| title=Thiazide-induced hyponatremia. | journal=Electrolyte Blood Press | year= 2010 | volume= 8 | issue= 1 | pages= 51-7 | pmid=21468197 | doi=10.5049/EBP.2010.8.1.51 | pmc=3041494 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21468197 }}</ref> | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal, increased with thiazides<ref name="Loffing2004">{{cite journal|last1=Loffing|first1=J.|title=Paradoxical Antidiuretic Effect of Thiazides in Diabetes Insipidus: Another Piece in the Puzzle|journal=Journal of the American Society of Nephrology|volume=15|issue=11|year=2004|pages=2948–2950|issn=1046-6673|doi=10.1097/01.ASN.0000146568.82353.04}}</ref> | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |No effect | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |No effect | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cerebral salt-wasting syndrome]]<ref name="pmid20066633">{{cite journal| author=Ozdemir H, Aycan Z, Degerliyurt A, Metin A| title=The treatment of cerebral salt wasting with fludrocortisone in a child with lissencephaly. | journal=Turk Neurosurg | year= 2010 | volume= 20 | issue= 1 | pages= 100-2 | pmid=20066633 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20066633 }}</ref> | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Low | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Improves urine osmolarity | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |No effect | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
|- | |||
! rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Impaired urinary concentration | |||
! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Low ADH | |||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Central diabetes insipidus]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Increased | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Low | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Low | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |No improvement | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Urine osmolarity improves | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Nephrogenic diabetes insipidus]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Increased | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Low | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |No improvement | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |No improvement | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
|- | |||
! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Renal disease | |||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Renal tubular acidosis]]<ref name="pmid19721811">{{cite journal| author=Pereira PC, Miranda DM, Oliveira EA, Silva AC| title=Molecular pathophysiology of renal tubular acidosis. | journal=Curr Genomics | year= 2009 | volume= 10 | issue= 1 | pages= 51-9 | pmid=19721811 | doi=10.2174/138920209787581262 | pmc=2699831 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19721811 }}</ref> | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |±<ref name="pmid29178965">{{cite journal| author=Ranawaka R, Dayasiri K, Gamage M| title=A child with distal (type 1) renal tubular acidosis presenting with progressive gross motor developmental regression and acute paralysis. | journal=BMC Res Notes | year= 2017 | volume= 10 | issue= 1 | pages= 618 | pmid=29178965 | doi=10.1186/s13104-017-2949-2 | pmc=5702097 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29178965 }}</ref> | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Increased | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Bartter syndrome]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
|- | |||
! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Miscellaneous | |||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Benign Prostatic Hyperplasia (BPH)]]<ref name="pmid16379182">{{cite journal| author=Yoong HF, Sundaram MB, Aida Z| title=Prevalence of nocturnal polyuria in patients with benign prostatic hyperplasia. | journal=Med J Malaysia | year= 2005 | volume= 60 | issue= 3 | pages= 294-6 | pmid=16379182 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16379182 }}</ref> | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
|- | |||
|} | |||
==Differential diagnosis== | ==Differential diagnosis== | ||
Line 7: | Line 173: | ||
<span style="font-size:85%">'''Abbreviations:''' | <span style="font-size:85%">'''Abbreviations:''' | ||
AP= Anteroposterior, CXR= [[Chest X-ray]], CT= [[Computed tomography]], ABG= [[Arterial blood gas]], V/Q= [[Ventilation/perfusion scan]] , EKG= [[Electrocardiogram]], COPD= [[Chronic obstructive pulmonary disease]], BNP= [[Brain natriuretic peptide]], DVT= [[Deep vein thrombosis]], HRCT= [[High Resolution CT]], IgE= [[Immunoglobulin E]] | AP= Anteroposterior, CXR= [[Chest X-ray]], CT= [[Computed tomography]], ABG= [[Arterial blood gas]], V/Q= [[Ventilation/perfusion scan]] , EKG= [[Electrocardiogram]], COPD= [[Chronic obstructive pulmonary disease]], BNP= [[Brain natriuretic peptide]], DVT= [[Deep vein thrombosis]], HRCT= [[High Resolution CT]], IgE= [[Immunoglobulin E]]</span> | ||
{| align="center" | {| align="center" | ||
Line 35: | Line 201: | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard | ||
|- | |- | ||
! rowspan=" | ! rowspan="14" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Respiratory | ||
! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Airway | ! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Airway | ||
disorder | disorder | ||
Line 72: | Line 238: | ||
* Throat culture in intubated patients | * Throat culture in intubated patients | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Lateral neck X ray | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Lateral neck X ray | ||
* [[Thumbprint sign]](swollen epiglottis) | * [[Thumbprint sign]] (swollen epiglottis) | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[Laryngoscopy]] | * [[Laryngoscopy]] | ||
Line 94: | Line 260: | ||
*[[Wheezing]] | *[[Wheezing]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* ABGs | * [[ABG|ABGs]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |CXR | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |CXR | ||
* Hyperinflation(children) | * Hyperinflation (children) | ||
* [[Atelectasis]](adults) | * [[Atelectasis]] (adults) | ||
* Objects | * Objects | ||
[[CT scan]] | [[CT scan]] | ||
Line 150: | Line 316: | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings | ||
|- | |- | ||
! rowspan=" | ! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Parenchymal | ||
disorder | disorder | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pneumonia]] | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pneumonia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
Line 196: | Line 331: | ||
* [[Pleural friction rub]] | * [[Pleural friction rub]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* ABGs | * [[ABG|ABGs]] | ||
* Leukocytosis | * Leukocytosis | ||
* Pancytopenia | * Pancytopenia | ||
Line 221: | Line 356: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ in interstitial lung disease | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ in [[interstitial lung disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* End expiratory[[wheeze]] | * End expiratory [[wheeze]] | ||
* Absent wheeze and breath sounds in severe form | * Absent [[wheeze]] and breath sounds in severe form | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* ABG | * [[ABG]] | ||
* [[Eosinophilia]] | * [[Eosinophilia]] | ||
* [[IgE]] | * [[IgE]] | ||
Line 246: | Line 381: | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cystic fibrosis]] | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cystic fibrosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |when infected | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |when infected | ||
Line 252: | Line 387: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Wheeze or crackles | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Wheeze]] or crackles | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Sputum stain and culture | * Sputum stain and culture | ||
Line 275: | Line 410: | ||
** [[Pancreatic insufficiency]] | ** [[Pancreatic insufficiency]] | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[COPD]] | |||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |COPD | |||
(Severe [[emphysema]]) | (Severe [[emphysema]]) | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | ||
Line 301: | Line 422: | ||
* Reduced breath sounds | * Reduced breath sounds | ||
* Prolonged expiration | * Prolonged expiration | ||
* Wheeze | * [[Wheeze]] | ||
* Inspiratory [[crackles]] | * Inspiratory [[crackles]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[Hematocrit]] | * [[Hematocrit]] | ||
* ABG | * [[ABG]] | ||
* Sputum staining and culture | * Sputum staining and culture | ||
* [[Alpha 1-antitrypsin deficiency laboratory tests|Alpha 1-antitrypsin test]] | * [[Alpha 1-antitrypsin deficiency laboratory tests|Alpha 1-antitrypsin test]] | ||
Line 321: | Line 442: | ||
* [[Right heart failure]] | * [[Right heart failure]] | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[ | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Disease | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Central | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Dyspnea | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Fever | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Chest pain | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Clubbing | |||
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral edema | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Auscultation | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Lab Findings | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings | |||
|- | |||
! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Pulmonary vascular disorders | |||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Massive [[pulmonary embolism]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | |||
* Reduced breath sounds | |||
* Rales, crackles | |||
* Loud [[P2]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | |||
* [[ABG|ABGs]] | |||
* D-dimer | |||
* EKG | |||
* [[BNP]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | |||
* CXR | |||
* V/Q scan | |||
* Spiral [[CT pulmonary angiogram]] | |||
* Venous ultrasound for [[DVT]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | |||
* Spiral [[CT pulmonary angiogram]] | |||
* [[Ventilation/perfusion scan]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | |||
* [[Tachycardia]] | |||
* [[Shock]] | |||
* [[Pulmonary hypertension]] can occur | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pulmonary arterio-venous malformation]]<ref name="pmid11930021">{{cite journal |vauthors=Khurshid I, Downie GH |title=Pulmonary arteriovenous malformation |journal=Postgrad Med J |volume=78 |issue=918 |pages=191–7 |year=2002 |pmid=11930021 |pmc=1742331 |doi= |url=}}</ref><ref name="pmid19568398">{{cite journal |vauthors=Doshi HM, Robinson S, Chalhoub T, Jack S, Denison A, Gibson G |title=Massive spontaneous hemothorax during the immediate postpartum period |journal=Tex Heart Inst J |volume=36 |issue=3 |pages=247–9 |year=2009 |pmid=19568398 |pmc=2696501 |doi= |url=}}</ref><ref name="pmid1554132">{{cite journal |vauthors=Chanatry BJ |title=Acute hemothorax owing to pulmonary arteriovenous malformation in pregnancy |journal=Anesth. Analg. |volume=74 |issue=4 |pages=613–5 |year=1992 |pmid=1554132 |doi= |url=}}</ref> | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
* Pulmonary bruit | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | |||
* [[CBC]] | |||
* [[ABG]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |CXR | |||
* Round/oval mass | |||
** lobulated | |||
** well defined | |||
* Connecting vessel in hilum | |||
* [[Hemothorax]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[ | * [[Pulmonary angiography]] | ||
* Contrast [[echocardiography]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Classic triad of [[dyspnea on exertion]], [[cyanosis]] and [[clubbing]] | |||
* | * [[Cerebral arteriovenous malformation]] | ||
* [[ | * [[Pregnancy]] can increase the size | ||
* | |||
|- | |- | ||
! rowspan=" | ! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Chest | ||
wall | wall | ||
Line 362: | Line 534: | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pneumothorax]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pneumothorax]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
Line 368: | Line 540: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
*Decreased breath sounds | |||
*[[Wheezing]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 689: | Line 849: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
|- | |- | ||
! colspan="2" rowspan=" | ! colspan="2" rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Miscellaneous | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Shock]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Shock]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | ||
Line 713: | Line 873: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 735: | Line 881: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
Line 742: | Line 888: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*[[Complete blood count|CBC]] | |||
*Fingerstick glucose (Hyperglycemia) | |||
*EKG- | |||
**J wave | |||
**Sinus bradycardia | |||
**Prolongation of all ECG intervals. | |||
*Serum electrolytes -K+ and calcium | |||
*[[BUN]] and [[creatinine]] | |||
*[[PT]], [[PTT]] | |||
*S. [[lactate]] | |||
*ABG | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*'''Mild hypothermia''': core temperature 32 to 35°C ; | |||
**[[Confusion]] | |||
**[[Tachycardia]] | |||
**Increased shivering. | |||
*'''Moderate hypothermia''': 28 to 32°C | |||
**[[Lethargy]] | |||
**[[Bradycardia]] | |||
**[[Arrhythmia]] | |||
**Decreased shivering. | |||
*'''Severe hypothermia''': <28°C | |||
**[[Coma]] | |||
**[[Hypotension]] | |||
**[[Arrhythmias|Arrhythmia]] | |||
**[[Pulmonary edema]] | |||
**Rigidity | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Drugs† | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |Drugs† | ||
Line 762: | Line 941: | ||
|} | |} | ||
|} | |} | ||
==References== | |||
{{reflist|2}} |
Latest revision as of 21:45, 11 May 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Differential diagnosis
Abbreviations: Na= Natrium/ Sodium, ADH= Antidiuretic hormone
POLYURIA[1]
Mechanism | Etiology | Clinical manifestations | Paraclinical findings | Comments | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms and signs | Lab findings/Urine exam | |||||||||||||
Dysuria | Nocturia | Hesitancy | Dribbling | Hematuria | Proteinuria | Serum osmolarity | S. ADH | Urine osmolarity | Water deprivation test | ADH administration | ||||
Increased intake of fluid | Psychogenic polydipsia[2] | – | – | – | – | – | – | Normal | Normal | Low | Improves urine osmolarity | No improvement | Increased thirst | |
Increased solute excretion | Osmotic causes | Diabetes mellitus[3] | – | ± | – | – | – | Late stage | High in Type 2 | Normal | Normal | No effect | No effect | Hyperosmolar hyperglycemic state |
Salt loss | Diuretics | – | + | – | + | – | ± | Normal | Raised[4] | Normal, increased with thiazides[5] | No effect | No effect | ||
Cerebral salt-wasting syndrome[6] | – | – | – | – | – | – | Normal | Normal | Low | Improves urine osmolarity | No effect | |||
Impaired urinary concentration | Low ADH | Central diabetes insipidus | – | + | – | – | ± | ± | Increased | Low | Low | No improvement | Urine osmolarity improves | |
Nephrogenic diabetes insipidus | – | + | – | – | ± | ± | Increased | Normal | Low | No improvement | No improvement | |||
Renal disease | Renal tubular acidosis[7] | ± | ±[8] | – | – | ± | + | Increased | ||||||
Bartter syndrome | ||||||||||||||
Miscellaneous | Benign Prostatic Hyperplasia (BPH)[9] | + | + | + | + | ± | – | Normal |
Differential diagnosis
Abbreviations: AP= Anteroposterior, CXR= Chest X-ray, CT= Computed tomography, ABG= Arterial blood gas, V/Q= Ventilation/perfusion scan , EKG= Electrocardiogram, COPD= Chronic obstructive pulmonary disease, BNP= Brain natriuretic peptide, DVT= Deep vein thrombosis, HRCT= High Resolution CT, IgE= Immunoglobulin E
|
References
- ↑ Bhasin, Bhavna; Velez, Juan Carlos Q. (2016). "Evaluation of Polyuria: The Roles of Solute Loading and Water Diuresis". American Journal of Kidney Diseases. 67 (3): 507–511. doi:10.1053/j.ajkd.2015.10.021. ISSN 0272-6386.
- ↑ Mellinger RC, Zafar MS (1983). "Primary polydipsia. Syndrome of inappropriate thirst". Arch Intern Med. 143 (6): 1249–51. PMID 6860053.
- ↑ Ahloulay M, Schmitt F, Déchaux M, Bankir L (1999). "Vasopressin and urinary concentrating activity in diabetes mellitus". Diabetes Metab. 25 (3): 213–22. PMID 10499190.
- ↑ Hwang KS, Kim GH (2010). "Thiazide-induced hyponatremia". Electrolyte Blood Press. 8 (1): 51–7. doi:10.5049/EBP.2010.8.1.51. PMC 3041494. PMID 21468197.
- ↑ Loffing, J. (2004). "Paradoxical Antidiuretic Effect of Thiazides in Diabetes Insipidus: Another Piece in the Puzzle". Journal of the American Society of Nephrology. 15 (11): 2948–2950. doi:10.1097/01.ASN.0000146568.82353.04. ISSN 1046-6673.
- ↑ Ozdemir H, Aycan Z, Degerliyurt A, Metin A (2010). "The treatment of cerebral salt wasting with fludrocortisone in a child with lissencephaly". Turk Neurosurg. 20 (1): 100–2. PMID 20066633.
- ↑ Pereira PC, Miranda DM, Oliveira EA, Silva AC (2009). "Molecular pathophysiology of renal tubular acidosis". Curr Genomics. 10 (1): 51–9. doi:10.2174/138920209787581262. PMC 2699831. PMID 19721811.
- ↑ Ranawaka R, Dayasiri K, Gamage M (2017). "A child with distal (type 1) renal tubular acidosis presenting with progressive gross motor developmental regression and acute paralysis". BMC Res Notes. 10 (1): 618. doi:10.1186/s13104-017-2949-2. PMC 5702097. PMID 29178965.
- ↑ Yoong HF, Sundaram MB, Aida Z (2005). "Prevalence of nocturnal polyuria in patients with benign prostatic hyperplasia". Med J Malaysia. 60 (3): 294–6. PMID 16379182.
- ↑ Cherry, James D. (2008). "Croup". New England Journal of Medicine. 358 (4): 384–391. doi:10.1056/NEJMcp072022. ISSN 0028-4793.
- ↑ Khurshid I, Downie GH (2002). "Pulmonary arteriovenous malformation". Postgrad Med J. 78 (918): 191–7. PMC 1742331. PMID 11930021.
- ↑ Doshi HM, Robinson S, Chalhoub T, Jack S, Denison A, Gibson G (2009). "Massive spontaneous hemothorax during the immediate postpartum period". Tex Heart Inst J. 36 (3): 247–9. PMC 2696501. PMID 19568398.
- ↑ Chanatry BJ (1992). "Acute hemothorax owing to pulmonary arteriovenous malformation in pregnancy". Anesth. Analg. 74 (4): 613–5. PMID 1554132.